Skip to main content

Leukemia

CPX-351 Improves Posttransplant Survival in Older Patients with High-Risk Acute Myeloid Leukemia

Strategies to Reduce the Use of Tyrosine Kinase Inhibitors in CML

Chemotherapy-Free Induction with Ibrutinib plus Rituximab Shows Unprecedented Efficacy in MCL

Refining the Use of CAR T-Cells in Patients with Acute Lymphoblastic Leukemia

CAR T-Cell Therapy Produces High Response Rates in Refractory B-Cell Malignancies

Nilotinib Yields Better Rates of Molecular Response Than Imatinib in Frontline Setting

Ibrutinib a New Standard of Care for Elderly Patients with Chronic Lymphocytic Leukemia

Idelalisib Improves Survival When Added to Bendamustine plus Rituximab in Patients with CLL

Immunotherapy with Blinatumomab Prolongs Survival in Acute Lymphoblastic Leukemia

Adding Ibrutinib to Standard Therapy Reduces Disease Progression by 80% in Previously Treated Patients with CLL

1
2
3
4
5
6
7

Page 4 of 7
Results 31 - 40 of 70